AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2020
Jun 12, 2020
31046_dirs_2020-06-12_3cb07a4a-3532-44b8-8ff1-557bd9d227da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-06-11
Reporting Person: Svoronos Dawn (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-11 | Common Stock | S | 364 | $48.36 | Disposed | 26286 | Direct |
Footnotes
F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 687 RSUs from a January 29, 2020 grant of 1,650 RSUs.
More from PTC THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Board/Management Information
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20